IRD Opus Genetics, Inc.
Healthcare$4.26-0.70%ClosedMarket Cap: $346.7M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$8.67
Target (Median)
$9.00
Target Range
$7.00 - $10.00
Upside from current price: 103.5%
Rating Distribution
2 Strong Buy14 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Citizens | maintain | Market Outperform | Market Outperform |
| 2026-03-12 | Wedbush | maintain | Outperform | Outperform |
| 2026-03-12 | Chardan Capital | maintain | Buy | Buy |
| 2026-03-02 | BTIG | maintain | Buy | Buy |
| 2026-01-28 | BTIG | maintain | Buy | Buy |
| 2025-11-13 | Chardan Capital | maintain | Buy | Buy |
| 2025-06-27 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.74 | $15.5M | 10 |
| Sun Dec 31 | $-0.44 | $30.9M | 9 |
| Mon Dec 31 | $0.12 | $166.2M | 3 |
| Tue Dec 31 | $0.81 | $316.0M | 3 |